Navigation Links
Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults
Date:10/26/2008

red in 10.3 percent of subjects treated with PREZISTA. Discontinuation due to rash was 0.5 percent. PREZISTA should be discontinued if severe rash develops.

PREZISTA should be used with caution in patients with known sulfonamide allergy.

New-onset or exacerbations of pre-existing diabetes mellitus, hyperglycemia, and increased bleeding in hemophiliacs have been reported in patients receiving protease inhibitors. Initiation or dose adjustments of insulin or oral hypoglycemic agents may be required. A causal relationship between protease inhibitors and these events has not been established.

Redistribution and/or accumulation of body fat have been observed in patients receiving ARV therapy. The causal relationship, mechanism, and long-term consequences of these events have not been established.

Immune reconstitution syndrome has been reported in patients treated with ARV therapy.

The potential for HIV cross-resistance among protease inhibitors has not been fully explored in PREZISTA/r treated patients.

PREZISTA/r is not recommended for use in patients with severe hepatic impairment. There are no pharmacokinetic or safety data available in patients with severe hepatic impairment.

PREZISTA should be used during pregnancy only if the potential benefit justifies the potential risk. No adequate and well-controlled studies have been conducted in pregnant women.

In treatment-naive adult patients receiving a PREZISTA/r-containing regimen, the most common adverse drug reactions (> or = 2 percent) reported of at least moderate to severe intensity (> or = Grade 2) were diarrhea (6 percent), headache (5 percent), abdominal pain (4 percent), nausea (3 percent), vomiting (2 percent), and rash (2 percent).

In treatment-experienced adult patients receiving a PREZISTA/r-containing regimen, the most common adverse drug reactions (> or = 2 percent) reported of at least moderate to severe intensity (> or = Grade 2) were diarrh
'/>"/>

SOURCE Tibotec Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long-Term Results
2. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
3. Sexual Function Affected by Stem Cell Transplant According to Long-Term Study
4. Neupro(R) (Rotigotine Transdermal System) Effective in Controlling Early Morning Motor Impairment and Generally Well-Tolerated for Long-Term Use in Patients with Parkinsons Disease
5. Horizon Therapeutics Initiates Long-Term Phase 3 Safety Study for Lead Product Candidate HZT-501
6. New Analyses of Long-Term LIALDA(TM) (mesalamine) Data Presented at ACG
7. Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system)
8. Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme
9. Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
10. Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus
11. Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... /PRNewswire-iReach/ -- The 2013 Pharma ChemOutsourcing Show slated for ... number of "Emerging" small molecule biotech company chemists ... .  "No one saw this coming", commented ... still 4 months away and we may end up ... surprise and great news for attendees". Thecurrent list of ...
(Date:5/21/2013)... announces the list of stocks featured in the Analyst ... the latest news and events impacting stocks and the ... Actavis, Inc.,s (NYSE: ACT ), BP plc (NYSE: ... Petrobras (NYSE: PBR ) and Devon Energy Corporation ... ) Get the most recent insight ...
(Date:5/21/2013)... May 21, 2013  Decision Resources, one ... firms for pharmaceutical and healthcare issues, finds ... on key efficacy endpoints, including overall survival ... most influence over surveyed U.S. and European ... positive, HER2-negative breast cancer. The two novel ...
Breaking Medicine Technology:Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show 2The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 2The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 3The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 4The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 5Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer 2
... , NANTONG, China , ... the "Company") (OTC Bulletin Board: SNBP) is pleased to,announce ... KuTai (Cisatracurium Besylate), for coverage under National Basic,Medical Insurance, ... KuTai (Cisatracurium Besylate), on the market ...
... , MIAMI , Jan. ... established an emergency fund for Haiti ,s Children called ... Haitian earthquake victims expected to arrive at Jackson Memorial Hospital ... www.wonderfund.org .  The IKF,s Wonderfund™, is a program of ...
Cached Medicine Technology:China's Basic Medical Insurance to Cover Sinobiopharma's Flagship Product 2China's Basic Medical Insurance to Cover Sinobiopharma's Flagship Product 3IKF's Wonderfund(TM) Needs Support for Haiti's Children 2
(Date:5/21/2013)... May 21, 2013 The team at Comfort ... help a new mom pick a nursing pillow. , ... of both mom and baby. , In a ... fabric and added features. Designers at Comfort & Harmony, ... pillow. , SHAPE: The nursing pillow needs to fit a ...
(Date:5/21/2013)... 2013 Residents in St. Petersburg, FL ... now that Dr. David Sherberg, DMD, has joined Coast ... Dr. Sherberg provides preventive, restorative and cosmetic dentistry to ... friendly team provide a wide variety of services ... canal therapy, crowns, bridges, dentures, dental implant restorations, veneers, ...
(Date:5/21/2013)... Representatives with Hammerhead Bicycles announced today that ... the company has achieved its overall goal of becoming a ... to move Hammerhead Bicycles from a house brand to a ... , Robertson explained that the bike shop will go forward ... on all things 29er and 650b. , “The ...
(Date:5/21/2013)... Austin, Texas (PRWEB) May 21, 2013 ... intelligence and process automation applications for video collaboration, ... The innovative vRating index evaluates key performance metrics ... to have an immediate, aggregated indicator of the ... part of the Vyopta vAnalytics™ application, the vRating™ ...
(Date:5/21/2013)... May 21, 2013 Benefit Express Services, ... medium, and small organizations, will be hosting a free ... team from Findley Davies. The presentation will focus on ... in compliance with new Health Care Reform Requirements. The ... employees. , “Benefit Express regularly hosts free educational ...
Breaking Medicine News(10 mins):Health News:Comfort and Harmony™ Shares Tips on What to Look for in a Nursing Pillow 2Health News:Comfort and Harmony™ Shares Tips on What to Look for in a Nursing Pillow 3Health News:Coast Dental Pasadena Welcomes Dr. David Sherberg 2Health News:Coast Dental Pasadena Welcomes Dr. David Sherberg 3Health News:Hammerhead Bicycles Now a Standalone Brand 2Health News:New vRating™ Video and Unified Communications Scoring System Delivers Innovative Approach to Measure Performance and ROI for Collaboration Networks 2Health News:New vRating™ Video and Unified Communications Scoring System Delivers Innovative Approach to Measure Performance and ROI for Collaboration Networks 3Health News:Benefit Express to Host Workplace Wellness Webinar 2
... to slow down aging. Recent research has revealed that calorie ... the Wisconsin National Primate Research Center laboratory, rhesus monkey Matthias ... getting a face full of wrinkles. ,However in ... of Matthias’s lab mates, Rudy, although a little older is ...
... has been a dramatic increase in the number of statin ... the conference organised by the Royal College of Physicians of ... was easier to offer a prescription than to persuade people ... people with a relatively low risk of heart disease were ...
... According to a recent study, there was a significant reduction ... when compared to those who did not. ,This ... Gynecology.,Menstruation, pregnancy and lactation deprives a woman of her iron ... risk of iron deficiency. ,This study investigated the ...
... be relieved by music therapy.// ,Researchers from ... hospitals and found improvement in the symptoms of schizophrenic ... music. ,"We have known for some time ... these have only been used when people are fairly ...
... between antidepressant prescriptions and the rates of suicide ... contradicts the Food and Drug Administration's "black box" ... known as SSRI drugs. ,The University of ... November issue of the American Journal of Psychiatry. ...
... United Nations children's agency has launched the first online game ... HIV and Aids. ,The game is named as ... several different scenarios so that he importance of prevention and ... around 80% of young people do not know how to ...
Cached Medicine News:Health News:Lesser Calories for Longer Life 2Health News:Increased Warning over heart drugs 2Health News:Iron intake reduces risk of infertility 2Health News:Antidepressants Linked to Lower Child Suicide Rates 2
Liquichek Hematology Control (A) is an assayed hematology control for evaluating the performance of Abbott Cell-Dyn 1600, 1700, 3000, 3500 and 3700 analyzers with 5-part differential technology....
... Liquichek ToRCH Plus Control ... used to monitor the performance ... serology instruments and assays. A ... control allow you to monitor ...
Liquichek™ Ethanol/Ammonia Control is a liquid product used to monitor ethanol and ammonia test procedures in the clinical laboratory....
Liquid Assayed and Unassayed Multiqual Controls are comprehensive, liquid, human serum based chemistry controls, available in three levels....
Medicine Products: